Thibaut Angevin

Director Cmc Proteins @BioNTech SE

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Dec 2022 — Present

Director Cmc Proteins @BioNTech SE

View department →

Munich, DE

Technical Lead for Drug Substance, focusing on Cell Line Development (CLD) and Upstream Processing (USP), from Preclinical to Phase Lead Technology Transfers, Scale-ups and scale-out projects- Lead Process Characterization and Process Performance Qualification projects- Lead Biostatistician and primary point of contact, specializing in statistical strategy, study design, and data-driven decision making- Develop, evaluate, and implement AI-driven solutions for data management and predictive modelling in bioprocessing operations- Draft regulatory CMC documentation for IND/IMPD and BLA applications- Lead due diligences for acquisition and partnership, focusing on CLD and USP- Lead CDMO selection for production, from Preclinical to Commercial.

EDUCATION

2005 — 2006

University of Strasbourg

Master of Science (M.Sc.), Genomics of microorganisms

1999 — 2001

CPGE Albert Schweitzer

N.A., Mathématiques, Physique

2007 — 2011

The University of Sheffield

PH.D. 2007, Department of Molecular Biology and Biotechnology

2001 — 2005

ENSTBB Bordeaux INP

Ingénieur, Biotechnologie

SKILLS

WritingMolecular CloningTransient TransfectionBiochemistryBiotechnologyProtein PurificationMammalian Cell CultureProtein ExpressionPolymerase Chain Reaction (Pcr)Prince2Cell BiologyMicroscopyOncologyGeneticsBiological DatabasesChoWestern BlottingLife SciencesProject ManagementCell CultureBioinformaticsMolecular BiologyFluorescence MicroscopyTeam ManagementWritten & Oral Presentation Skills

ABOUT THIBAUT ANGEVIN

Director CMC Proteins

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Thibaut Angevin — Director Cmc Proteins at BioNTech SE in Munich, DE | Unifers